ES2118939T3 - Peptido para el diagnostico e inmunizacion contra la infeccion con t.cruzi. - Google Patents

Peptido para el diagnostico e inmunizacion contra la infeccion con t.cruzi.

Info

Publication number
ES2118939T3
ES2118939T3 ES93905886T ES93905886T ES2118939T3 ES 2118939 T3 ES2118939 T3 ES 2118939T3 ES 93905886 T ES93905886 T ES 93905886T ES 93905886 T ES93905886 T ES 93905886T ES 2118939 T3 ES2118939 T3 ES 2118939T3
Authority
ES
Spain
Prior art keywords
peptide
ala glu
diagnosis
pro lys
glu pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93905886T
Other languages
English (en)
Inventor
Steven G Reed
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Application granted granted Critical
Publication of ES2118939T3 publication Critical patent/ES2118939T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE DESCRIBE UN PEPTIDO ANTIGENICO QUE COMPRENDE AL MENOS 15 AMINOACIDOS TENIENDO LA SECUENCIA ALA GLU PRO LYS X ALA GLU PRO LYS X ALA GLU PRO LYS X, DONDE X ES PRO O SER. ESTE PEPTIDO ES UTIL EN UN ENSAYO ELISA, PARA DETECTAR ANTICUERPOS ESPECIFICOS A LA INFECCION T. CRUZI Y ENFERMEDAD DE CHAGAS. ESTE PEPTIDO ES ADEMAS UTIL EN UNA COMPOSICION DE VACUNA PARA INMUNIZAR A UN INDIVIDUO Y EVITAR LA ENFERMEDAD DE CHAGAS AL EXPONERLE AL T. CRUZI.
ES93905886T 1992-02-14 1993-02-11 Peptido para el diagnostico e inmunizacion contra la infeccion con t.cruzi. Expired - Lifetime ES2118939T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/836,642 US5304371A (en) 1992-02-14 1992-02-14 Peptide for diagnosing and immunizing against T. cruzi infection

Publications (1)

Publication Number Publication Date
ES2118939T3 true ES2118939T3 (es) 1998-10-01

Family

ID=25272399

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93905886T Expired - Lifetime ES2118939T3 (es) 1992-02-14 1993-02-11 Peptido para el diagnostico e inmunizacion contra la infeccion con t.cruzi.

Country Status (8)

Country Link
US (2) US5304371A (es)
EP (1) EP0649475B1 (es)
BR (1) BR9305995A (es)
CA (1) CA2129747C (es)
DE (1) DE69319909D1 (es)
ES (1) ES2118939T3 (es)
MX (1) MX9300787A (es)
WO (1) WO1993016199A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5876734A (en) 1994-03-24 1999-03-02 Kirchhoff; Louis V. Polypeptides for diagnosing infection with Trypanosoma cruzi
US6013268A (en) 1994-04-22 2000-01-11 Corixa Corporation Methods for enhancement of protective immune responses
US5879687A (en) * 1994-04-22 1999-03-09 Corixa Corporation Methods for enhancement of protective immune responses
JP3556228B2 (ja) * 1994-07-25 2004-08-18 ロシュ ダイアグノスティックス ゲーエムベーハー 複数の抗原を使用した特異的免疫グロブリンの測定
US5756662A (en) * 1995-03-14 1998-05-26 Corixa Corporation Compounds and methods for the detection of T. cruzi infection
US5912166A (en) * 1995-04-21 1999-06-15 Corixa Corporation Compounds and methods for diagnosis of leishmaniasis
US6419933B1 (en) * 1995-11-14 2002-07-16 Corixa Corporation Compounds and methods for the detection and prevention of T.cruzi infection
US5916572A (en) * 1995-11-14 1999-06-29 Corixa Corporation Compounds and methods for the detection and prevention of T. cruzi infection
US6228372B1 (en) 1997-04-15 2001-05-08 Corixa Corporation Compounds and methods for the detection and prevention of T. cruzi infection
US6054135A (en) * 1996-11-14 2000-04-25 Corixa Compounds and methods for the detection and prevention of T. cruzi infection
WO2000062828A1 (en) * 1996-04-30 2000-10-26 Medtronic, Inc. Autologous fibrin sealant and method for making the same
US6134846A (en) * 1997-11-18 2000-10-24 Lamb; Charles Modular slatwall system
US6875584B1 (en) 1999-03-02 2005-04-05 University Of Georgia Research Foundation, Inc. Prophylactic and therapeutic immunization against protozoan infection and disease
AR027370A1 (es) * 2000-02-17 2003-03-26 Lg Chemical Ltd Inmunoensayo y reactivo de diagnostico para malaria, y correspondientes metodos de preparacion, vectores de expresion y transformantes
US9028844B2 (en) 2006-03-17 2015-05-12 Vib Vzw Vaccine against Trypanosoma cruzi infection
US7749717B2 (en) * 2006-10-19 2010-07-06 Abbott Laboratories Methods for the detection and diagnosis of Trypanosoma cruzi infection
WO2010003085A1 (en) 2008-07-03 2010-01-07 Infectious Disease Research Institute Fusion proteins and their use in the diagnosis and treatment of leishmaniasis
WO2023114960A1 (en) * 2021-12-17 2023-06-22 The Administrators Of The Tulane Educational Fund Antigenic peptides and methods of use for diagnosis of chagas disease

Also Published As

Publication number Publication date
EP0649475A4 (en) 1995-12-20
DE69319909D1 (de) 1998-08-27
MX9300787A (es) 1993-11-01
WO1993016199A1 (en) 1993-08-19
US5304371A (en) 1994-04-19
EP0649475B1 (en) 1998-07-22
US5413912A (en) 1995-05-09
CA2129747C (en) 2001-04-17
CA2129747A1 (en) 1993-08-15
EP0649475A1 (en) 1995-04-26
BR9305995A (pt) 1997-03-11

Similar Documents

Publication Publication Date Title
ES2118939T3 (es) Peptido para el diagnostico e inmunizacion contra la infeccion con t.cruzi.
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
BR9810907A (pt) Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico
ES2138784T3 (es) Antigenos sinteticos para la deteccion de anticuerpos contra el virus de la hepatitis c.
KR900700507A (ko) Htlv-1 감염 검출용 합성 펩티드 항원
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
DK0969873T3 (da) Multiple carbonhydratholdige glycopeptid-antigener, vaccine indeholdende dem og anvendelse deraf
ES2194836T3 (es) Peptidos para su uso en vacunacion e induccion de anticuerpos neutralizantes contra el virus de la inmunodeficiencia humana.
DE69322872D1 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
ATE121754T1 (de) Vakzine gegen bordetella.
ATE94880T1 (de) Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung.
YU48525B (sh) Protein, dnk koji kodira protein, rekombinantni vektor koji obuhvata dnk i postupak za proizovodnju proteina
ES2117272T3 (es) Composiciones farmaceuticas orales que comprenden una proteina o peptido, un anticuerpo y esferas polimericas.
BR9611455A (pt) Compostos e métodos para a detecção e prevenção de infecção por t. cruzi.
ES2113356T3 (es) Peptidos con un determinante antigenico caracteristico para alfa-1-micro-globulina.
KR890006253A (ko) 가금류내의 E.coli septicaemia에 대한 백신
NO881661D0 (no) Humane rhinoviruspeptider.
DK0426314T3 (da) HIV-relaterede peptider
DK21191A (da) Polypeptid, dets anvendelse til afproevning for anti-ebna-anti-stoffer og diagnostisk proevesaet hertil
ATE201697T1 (de) Antigenen peptide mit glycinsubstitution
DE69123252D1 (de) Kreuzreaktive immunisierung gegen influenza
CL2004001062A1 (es) Una composicion de peptidos para la deteccion de la presencia de anticuerpos del hcv que comprende un peptido con una secuencia de aminoacidos determinada; un segmento del peptido con inmunorreactividad especifica para anticuerpos para hcv; un conjug
MX9707020A (es) Compuestos y metodos para la deteccion de infeccion por t. cruzi.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 649475

Country of ref document: ES